Related Experiment Video
Updated: Jul 28, 2025

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
Published on: September 26, 2018
[Telemedicine in cardiology - what is new?]
David Schneider1,2, Kerstin Köhler3,2, Friedrich Köhler3,2
1Deutsches Herzzentrum der Charité, Klinik für Kardiologie, Angiologie und Intensivmedizin, Berlin, Deutschland.
Insights
Telemedicine is now approved for specific heart failure (HF) patients in Germany, reducing mortality and morbidity. This digital care enhances patient outcomes through remote monitoring and advanced technologies.
Area of Science:
- Cardiology
- Digital Health
- Health Services Research
Context:
- The Federal Joint Committee (G-BA) in Germany has approved telemedicine for heart failure (HF) management.
- This marks a significant step in integrating digital health solutions into routine patient care.
- The approval targets a specific HF population with reduced left ventricular ejection fraction (LVEF < 40%).
Purpose:
- To summarize the recent approval and implementation of telemedicine for heart failure patients in Germany.
- To highlight the key aspects of this digital care method, including eligible patient populations and technological integration.
- To outline ongoing research directions aimed at expanding telemedicine's reach and capabilities in HF management.
Summary:
- Telemedicine demonstrates robust clinical efficacy in reducing mortality and morbidity in heart failure (HF) patients.
- Germany's G-BA has approved telemedicine for a defined HF population (LVEF < 40%) in outpatient settings.
- Implementation involves new technologies, patient education, and standard operating procedures for telemedical centers.
Impact:
- Facilitates wider adoption of telemonitoring for heart failure patients in Germany.
- Drives innovation in telemedical sensor technologies and AI applications for improved patient monitoring.
- Establishes a framework for digital health integration in chronic disease management, potentially improving patient outcomes and healthcare efficiency.
Abstract:
There is robust evidence for the clinical efficacy of telemedicine in heart failure (HF) patients to reduce mortality and morbidity. For the first time, the Federal Joint Committee (G-BA) has approved telemedicine for HF patients as a digital method of care for a well-defined heart failure population. Patients with HF and a reduced left ventricular ejection fraction (LVEF ) < 40 % are now eligible for telemonitoring in a real-world settings of out-patient care in Germany. The implementation of telemedicine in the German health care system is a complex process including the introduction of telemedical technologies, educational programs for the patients as well as the implementation of standard operating procedures (SOPs) for the staff of telemedical centers. The ongoing research in telemedicine in HF patients is focusing on three issues: a) research to extend the suitable HF-population for telemonitoring; b) research on new telemedical sensor technologies, e.g. a new pulmonary pressure measurement system (Cordella) and a system for wireless measurement of left atrial pressure (V-LAP); c) the introduction of methods of artifical intelligence (AI), e.g. the AI-based speech analysis using a smart phone to characterize the pulmonary fluid status.
Related Concept Videos
Issues And Trends In Healthcare Delivery System
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Current Trends in Nursing II
Pulse rhythm
Conversely, an irregular pulse pattern is termed dysrhythmia, stemming from disruptions in cardiac...
Coronary Artery Disease V: Interprofessional Care
Cardiomyopathy V: Interprofessional Care
Cardiac Catheterization I: Pre-Procedure Overview

